Trials / Unknown
UnknownNCT05369104
Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.
A Pilot, Multicenter, Randomized, Non-Comparative, Double-Blind Study of Phage Therapy in Patients With Hip or Knee Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR and Antibiotic Therapy.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- Phagenix · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pilot non comparative study assessing the clinical control of infection of DAIR + SAT +NaCl and DAIR + SAT + Phages anti-Staphylococcus aureus in patients with Staphylococcus aureus Prosthetic Joint Infection with an indication of DAIR + SAT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Anti-Staphylococcus aureus Bacteriophages | Single intra-articular injection |
Timeline
- Start date
- 2022-06-15
- Primary completion
- 2023-12-16
- Completion
- 2025-06-16
- First posted
- 2022-05-11
- Last updated
- 2022-06-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05369104. Inclusion in this directory is not an endorsement.